EDA services now subject to VAT

Services offered by the Egyptian Drug Authority will now be subject to a 14% VAT under a decision issued by the Egyptian Tax Authority, the Egyptian Drug Authority (EDA) announced in a statement (pdf). The EDA will for the first time collect and remit value-added taxes on services such as licensing medicinal and dietary supplement products, running chemical and active ingredient tests, and the supervision of drug production. The levy came into effect as of 1 August.